Amphotropic but Not Atherotropic: Another Caveat for Adenoviral Gene Therapy

Overview

Journal J Clin Invest

Specialty General Medicine

Date 1995 Jun 1

PMID 7769084

Citations 3

Authors

W Casscells

J T Willerson

Affiliations

Soon will be listed here.

Citing Articles

Autoimmunity, immunologic tolerance, and gene therapy.

Chen Y Immunol Res. 1998; 17(1-2):33-40.

PMID: 9479565 DOI: 10.1007/BF02786428.

Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer.

Zhang H, Yang Y, Horton J, Samoilova E, Judge T, Turka L J Clin Invest. 1997; 100(8):1951-7.

PMID: 9329958 PMC: 508384. DOI: 10.1172/JCI119726.

Amphotropic but not atherotropic: another caveat for adenoviral gene therapy.

Casscells W, Willerson J J Clin Invest. 1995; 95(6):2425-6.

PMID: 7769084 PMC: 295908. DOI: 10.1172/JCI117938.

References

Chen J, Gamou S, Takayanagi A, Shimizu N . A novel gene delivery system using EGF receptor-mediated endocytosis. FEBS Lett. 1994; 338(2):167-9. DOI: 10.1016/0014-5793(94)80357-9. View

Nikkari S, Jarvelainen H, Wight T, Ferguson M, Clowes A . Smooth muscle cell expression of extracellular matrix genes after arterial injury. Am J Pathol. 1994; 144(6):1348-56. PMC: 1887477. View

Lincoff A, Topol E, ELLIS S . Local drug delivery for the prevention of restenosis. Fact, fancy, and future. Circulation. 1994; 90(4):2070-84. DOI: 10.1161/01.cir.90.4.2070. View

Schneider M, French B . The advent of adenovirus. Gene therapy for cardiovascular disease. Circulation. 1993; 88(4 Pt 1):1937-42. DOI: 10.1161/01.cir.88.4.1937. View

Casscells W, Willerson J . Amphotropic but not atherotropic: another caveat for adenoviral gene therapy. J Clin Invest. 1995; 95(6):2425-6. PMC: 295908. DOI: 10.1172/JCI117938. View

Yu Z, Biro S, Fu Y, Sanchez J, Smale G, Sasse J . Localization of basic fibroblast growth factor in bovine endothelial cells: immunohistochemical and biochemical studies. Exp Cell Res. 1993; 204(2):247-59. DOI: 10.1006/excr.1993.1031. View

Mitsuka M, Nagae M, Berk B . Na(+)-H+ exchange inhibitors decrease neointimal formation after rat carotid injury. Effects on smooth muscle cell migration and proliferation. Circ Res. 1993; 73(2):269-75. DOI: 10.1161/01.res.73.2.269. View

Biro S, Yu Z, Fu Y, Smale G, Sasse J, Sanchez J . Expression and subcellular distribution of basic fibroblast growth factor are regulated during migration of endothelial cells. Circ Res. 1994; 74(3):485-94. DOI: 10.1161/01.res.74.3.485. View

Anderson W . Making clinical grade gene therapy vectors. Hum Gene Ther. 1994; 5(8):925-6. DOI: 10.1089/hum.1994.5.8-925. View

10.

von der Leyen H, Gibbons G, Morishita R, Lewis N, Zhang L, Nakajima M . Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci U S A. 1995; 92(4):1137-41. PMC: 42653. DOI: 10.1073/pnas.92.4.1137. View

11.

Rome J, Shayani V, Flugelman M, Newman K, Farb A, Virmani R . Anatomic barriers influence the distribution of in vivo gene transfer into the arterial wall. Modeling with microscopic tracer particles and verification with a recombinant adenoviral vector. Arterioscler Thromb. 1994; 14(1):148-61. DOI: 10.1161/01.atv.14.1.148. View

12.

Mayor H . Defective parvoviruses may be good for your health!. Prog Med Virol. 1993; 40:193-205. View

13.

Casscells W, Lappi D, Olwin B, Wai C, SIEGMAN M, Speir E . Elimination of smooth muscle cells in experimental restenosis: targeting of fibroblast growth factor receptors. Proc Natl Acad Sci U S A. 1992; 89(15):7159-63. PMC: 49665. DOI: 10.1073/pnas.89.15.7159. View

14.

Flugelman M, Jaklitsch M, Newman K, Casscells W, Bratthauer G, Dichek D . Low level in vivo gene transfer into the arterial wall through a perforated balloon catheter. Circulation. 1992; 85(3):1110-7. DOI: 10.1161/01.cir.85.3.1110. View

15.

Miller N, Vile R . Targeted vectors for gene therapy. FASEB J. 1995; 9(2):190-9. DOI: 10.1096/fasebj.9.2.7781922. View

16.

Yang Y, Nunes F, Berencsi K, Gonczol E, Engelhardt J, Wilson J . Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nat Genet. 1994; 7(3):362-9. DOI: 10.1038/ng0794-362. View

17.

Wu K, Zoldhelyi P, Willerson J, Xu X, Wang L . Gene therapy for vascular diseases. Tex Heart Inst J. 1994; 21(1):98-103. PMC: 325138. View

18.

Ross R . The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993; 362(6423):801-9. DOI: 10.1038/362801a0. View

19.

Shelling A, Smith M . Targeted integration of transfected and infected adeno-associated virus vectors containing the neomycin resistance gene. Gene Ther. 1994; 1(3):165-9. View